BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Openfund//Deadlines//BG
CALSCALE:GREGORIAN
NAME:Openfund · Крайни срокове
X-WR-CALNAME:Openfund · Крайни срокове
X-WR-TIMEZONE:Europe/Sofia
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VTIMEZONE
TZID:Europe/Sofia
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:19970330T030000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:19971026T040000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:4a1e99a8-eb7f-5ed4-92f9-0b05a9cae06f
DTSTAMP:20261019T002700Z
DTSTART;VALUE=DATE:20270916
SUMMARY:Краен срок: Phase 1 including first-in-human clinical tria
 ls to test biomarker-guided medicines or multi-modal treatment interventio
 ns for patients with rare or very rare cancers or cancer subtypes
DESCRIPTION:HORIZON-MISS-2027-02-CANCER-03\nHorizon Europe (HORIZON)\nОф
 ициална страница на поканата: https://ec.europa.e
 u/info/funding-tenders/opportunities/portal/screen/opportunities/topic-det
 ails/HORIZON-MISS-2027-02-CANCER-03\nOpenfund: https://www.openfund.eu/bg/
 calls/sedia:HORIZON-MISS-2027-02-CANCER-03
URL:https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/o
 pportunities/topic-details/HORIZON-MISS-2027-02-CANCER-03
TRANSP:TRANSPARENT
BEGIN:VALARM
ACTION:DISPLAY
DESCRIPTION:Краен срок: Phase 1 including first-in-human clinical 
 trials to test biomarker-guided medicines or multi-modal treatment interve
 ntions for patients with rare or very rare cancers or cancer subtypes
TRIGGER:-P7D
END:VALARM
END:VEVENT
END:VCALENDAR